VALLON PHARMACEUTICALS
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.
VALLON PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.vallon-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 267 207 3606
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Current Employees Featured
David Baker President & CEO @ Vallon Pharmaceuticals
President & CEO
2019-01-01
Founder
Stock Details
Official Site Inspections
http://www.vallon-pharma.com Semrush global rank: 5.1 M Semrush visits lastest month: 1.6 K
- Host name: 172.67.160.85
- IP address: 172.67.160.85
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vallon Pharmaceuticals"
Vallon Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The Org
Vallon Pharmaceuticals (Nasdaq: VLON) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel abuse-deterrent medications for CNS …See details»
GRI Bio (Reverse Merger With Vallon Pharmaceuticals)
Contact Email info@vallon-pharma.com; Phone Number +1 267 207 3606; Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company. The Company is focused on …See details»
Vallon Pharma - VentureRadar
Vallon Pharmaceuticals Inc. is a private, clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new …See details»
Vallon Pharmaceuticals and GRI Bio Enter into Merger …
Dec 13, 2022 PHILADELPHIA, PA and LA JOLLA, CA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), and GRI Bio, Inc. (“GRI Bio”), a ...See details»
Vallon Pharmaceuticals Company Profile | Management and
Vallon Pharmaceuticals Profile and History Vallon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on …See details»
Vallon Pharmaceuticals - LinkedIn
Vallon Pharmaceuticals (Nasdaq: VLON) is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel abuse-deterrent medications for CNS …See details»
Vallon Pharmaceuticals Overview | SignalHire Company Profile
Vallon Pharmaceuticals is a public company that has been in the industry for 6 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: vallon …See details»
Vallon Pharmaceuticals - Overview, News & Similar companies
Apr 20, 2023 Who is Vallon Pharmaceuticals. Vallon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on …See details»
Vallon Pharmaceuticals CEO and key executive team | Craft.co
Vallon Pharmaceuticals's President & CEO, Director is David Baker. Other executives include Tim Whitaker, Chief Medical Officer; Leanne Kelly, Chief Financial Officer and 3 others. See the …See details»
Vallon Pharmaceuticals and GRI Bio conclude merger
Apr 24, 2023 Vallon bought 100% of the outstanding equity interests of GRI Bio (now GRI Bio Operations or Private GRI). This purchase was made through the reverse triangular merger of …See details»
Vallon Pharma
Adderall®is the most abused medicine among both college and high school students 1,2 TO DATE, THERE ARE NO TECHNOLOGIES TO CREATE AN ABUSE-DETERRENT …See details»
Vallon Pharma - VentureRadar
Vallon Pharmaceuticals Inc. is a private, clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new …See details»
Vallon Pharmaceuticals - Products, Competitors, Financials, …
Oct 2, 2021 Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel abuse-deterrent medications for central nervous system disorders. Use the …See details»
Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Apr 21, 2023 Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc. April 21, 2023 11:55 ET | Source: Vallon Pharmaceuticals Inc. Combined company will operate as GRI ...See details»
Vallon Pharma | VentureRadar
Similar Companies: Proniras USA Privately Held Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing tezampanel as a medical countermeasure …See details»
Vallon Pharmaceuticals - Craft
Oct 22, 2024 Vallon Pharmaceuticals has 1 employees at their 1 location. See insights on Vallon Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
Vallon Pharmaceuticals - PitchBook
Vallon Pharmaceuticals was founded in 2018. Where is Vallon Pharmaceuticals headquartered? Vallon Pharmaceuticals is headquartered in Philadelphia, PA. What is the size of Vallon …See details»
Document - SEC.gov
PHILADELPHIA, PA and LA JOLLA, CA, January 11, 2023 – Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), and GRI Bio, Inc. (“GRI Bio”), a privately held …See details»
Vallon Pharmaceuticals and GRI Bio Enter into Merger
Dec 13, 2022 Information regarding Vallon’s executive officers and directors is available in Vallon’s proxy statement on Schedule 14A for its 2022 annual meeting of stockholders, filed …See details»
Vallon Pharmaceuticals Inc. - Cruelty Free Investing
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel abuse-deterrent medications for central nervous system disorders. …See details»